Inozyme Pharma Inc (INZY) is higher by 32.61% in a Week, Should You Buy?

A rating of 95 puts Inozyme Pharma Inc (INZY) near the top of the Biotechnology industry according to InvestorsObserver. Inozyme Pharma Inc's score of 95 means it scores higher than 95% of stocks in the industry. Inozyme Pharma Inc also received an overall rating of 81, putting it above 81% of all stocks. Biotechnology is